1 | 1 | | HR0173LRB104 12658 MST 23404 r HR0173 LRB104 12658 MST 23404 r |
---|
2 | 2 | | HR0173 LRB104 12658 MST 23404 r |
---|
3 | 3 | | 1 HOUSE RESOLUTION |
---|
4 | 4 | | 2 WHEREAS, Prader-Willi syndrome is a complex genetic |
---|
5 | 5 | | 3 disorder that occurs in approximately 1 out of every 15,000 |
---|
6 | 6 | | 4 births and the most commonly known genetic cause of |
---|
7 | 7 | | 5 life-threatening obesity; and |
---|
8 | 8 | | 6 WHEREAS, Prader-Willi syndrome affects males and females |
---|
9 | 9 | | 7 with equal frequency and affects all races and ethnicities; |
---|
10 | 10 | | 8 and |
---|
11 | 11 | | 9 WHEREAS, Prader-Willi syndrome causes an extreme and |
---|
12 | 12 | | 10 insatiable appetite, often resulting in morbid obesity, which |
---|
13 | 13 | | 11 is the major cause of death for individuals with the syndrome; |
---|
14 | 14 | | 12 and |
---|
15 | 15 | | 13 WHEREAS, Prader-Willi syndrome also causes cognitive and |
---|
16 | 16 | | 14 learning disabilities as well as behavioral difficulties, such |
---|
17 | 17 | | 15 as obsessive-compulsive disorder and struggles with |
---|
18 | 18 | | 16 controlling emotions; and |
---|
19 | 19 | | 17 WHEREAS, The hunger, metabolic, and behavioral |
---|
20 | 20 | | 18 characteristics of Prader-Willi syndrome force affected |
---|
21 | 21 | | 19 individuals to require constant and lifelong supervision in a |
---|
22 | 22 | | 20 controlled environment; and |
---|
23 | 23 | | |
---|
24 | 24 | | |
---|
25 | 25 | | |
---|
26 | 26 | | HR0173 LRB104 12658 MST 23404 r |
---|
27 | 27 | | |
---|
28 | 28 | | |
---|
29 | 29 | | HR0173- 2 -LRB104 12658 MST 23404 r HR0173 - 2 - LRB104 12658 MST 23404 r |
---|
30 | 30 | | HR0173 - 2 - LRB104 12658 MST 23404 r |
---|
31 | 31 | | 1 WHEREAS, Studies have shown that there is a high morbidity |
---|
32 | 32 | | 2 and mortality rate for individuals with Prader-Willi syndrome; |
---|
33 | 33 | | 3 and |
---|
34 | 34 | | 4 WHEREAS, There is no known cure for Prader-Willi syndrome; |
---|
35 | 35 | | 5 and |
---|
36 | 36 | | 6 WHEREAS, Early diagnosis of Prader-Willi syndrome allows |
---|
37 | 37 | | 7 families to access treatment, intervention services, and |
---|
38 | 38 | | 8 support from health professionals, advocacy organizations, and |
---|
39 | 39 | | 9 other families who are dealing with the syndrome; and |
---|
40 | 40 | | 10 WHEREAS, Recently discovered treatments, such as human |
---|
41 | 41 | | 11 growth hormone, are improving the quality of life for |
---|
42 | 42 | | 12 individuals with the syndrome and offer new hope to families, |
---|
43 | 43 | | 13 but many difficult symptoms associated with Prader-Willi |
---|
44 | 44 | | 14 syndrome remain untreated; and |
---|
45 | 45 | | 15 WHEREAS, Increased research into Prader-Willi syndrome can |
---|
46 | 46 | | 16 lead to a better understanding of the disorder, more effective |
---|
47 | 47 | | 17 treatments, and an eventual cure for Prader-Willi syndrome; |
---|
48 | 48 | | 18 and |
---|
49 | 49 | | 19 WHEREAS, Increased research into Prader-Willi syndrome is |
---|
50 | 50 | | 20 likely to improve our understanding of common public health |
---|
51 | 51 | | 21 concerns, including childhood obesity and mental health; and |
---|
52 | 52 | | |
---|
53 | 53 | | |
---|
54 | 54 | | |
---|
55 | 55 | | |
---|
56 | 56 | | |
---|
57 | 57 | | HR0173 - 2 - LRB104 12658 MST 23404 r |
---|
58 | 58 | | |
---|
59 | 59 | | |
---|
60 | 60 | | HR0173- 3 -LRB104 12658 MST 23404 r HR0173 - 3 - LRB104 12658 MST 23404 r |
---|
61 | 61 | | HR0173 - 3 - LRB104 12658 MST 23404 r |
---|
62 | 62 | | 1 WHEREAS, Advocacy organizations have designated May as |
---|
63 | 63 | | 2 National Prader-Willi Syndrome Awareness Month; therefore, be |
---|
64 | 64 | | 3 it |
---|
65 | 65 | | 4 RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE |
---|
66 | 66 | | 5 HUNDRED FOURTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that |
---|
67 | 67 | | 6 we declare May 2025 as Prader-Willi Syndrome Awareness Month |
---|
68 | 68 | | 7 in the State of Illinois; and be it further |
---|
69 | 69 | | 8 RESOLVED, That we express our support for raising |
---|
70 | 70 | | 9 awareness and educating the public about Prader-Willi Syndrome |
---|
71 | 71 | | 10 and increasing research and funding into the causes and |
---|
72 | 72 | | 11 treatments of the disease. |
---|
73 | 73 | | |
---|
74 | 74 | | |
---|
75 | 75 | | |
---|
76 | 76 | | |
---|
77 | 77 | | |
---|
78 | 78 | | HR0173 - 3 - LRB104 12658 MST 23404 r |
---|